Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC)
NIAID will fund a center to coordinate clinical studies, data management, and regulatory support for autoimmune disease trials, including biostatistics, site monitoring, and collaboration with related research networks.
Funder: National Institutes of Health
Due Dates: June 4, 2026 (estimated, forecasted)
Funding Amounts: Estimated total: $8,000,000 | Expected number of awards: 1 | Single large cooperative agreement
Summary: Supports establishment of a coordinating center to provide statistical, clinical, and regulatory support for clinical trials in autoimmune diseases, mucosal immunology, and primary immune deficiencies.
Key Information: Forecasted opportunity; details and dates subject to change.
Description
The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, is seeking to establish an Autoimmune Diseases Statistical & Clinical Coordinating Center (AD-SCCC). This center will provide comprehensive support for clinical trials, including clinical study development, regulatory compliance (domestic and international), site monitoring, repository management, manuscript production, study archiving, and biostatistical support. The AD-SCCC will serve ongoing and future clinical trials in autoimmune diseases, mucosal immunology, and primary immune deficiencies. The center will also collaborate with the Division of Allergy, Immunology and Transplantation (DAIT) Clinical Data and Safety Management Center (CDSMC) and may be called upon to support other NIAID clinical trial networks as needed.
